They probably have it in as they’ve detailed the entire process, which unfortunately began with Rich Bright getting fired from BARDA. Generex was far in the process at that point. I asked about this on a CC early last summer. That led to the Rna mRna developer from GSK taking the top spot at BARDA and putting all his eggs in one basket.Timelines are often driven by money. They’ve come so far with this with none it’s amazing even if you or the market don’t see it. I want a CC after the IND is approved. Maybe Joe should conduct less of them until listed on a national exchange and do quarterly.